Clinical trial
Phase 2 Clinical Trial of FIsetin to Treat CArpal Tunnel Syndrome (FITCATS)
NCT05416515 is registered in ClinicalTrials.gov with Peter C. Amadio, M.D. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 2 Clinical Trial of FIsetin to Treat CArpal Tunnel Syndrome (FITCATS)
- Lead sponsor
- Peter C. Amadio, M.D.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 9, 2022
- Completion date
- January 24, 2025
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.